Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview

The development in the area of novel anticancer prodrugs (conjugates and complexes) has attracted growing attention from many research groups. The dangerous side effects of currently used anticancer drugs, including cisplatin and other platinum based drugs, as well their systemic toxicity is a drivi...

Full description

Bibliographic Details
Main Authors: Kinga Piorecka, Jan Kurjata, Wlodzimierz A. Stanczyk
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/17/9264
_version_ 1797521378233024512
author Kinga Piorecka
Jan Kurjata
Wlodzimierz A. Stanczyk
author_facet Kinga Piorecka
Jan Kurjata
Wlodzimierz A. Stanczyk
author_sort Kinga Piorecka
collection DOAJ
description The development in the area of novel anticancer prodrugs (conjugates and complexes) has attracted growing attention from many research groups. The dangerous side effects of currently used anticancer drugs, including cisplatin and other platinum based drugs, as well their systemic toxicity is a driving force for intensive search and presents a safer way in delivery platform of active molecules. Silicon based nanocarriers play an important role in achieving the goal of synthesis of the more effective prodrugs. It is worth to underline that silicon based platform including silica and silsesquioxane nanocarriers offers higher stability, biocompatibility of such the materials and pro-longed release of active platinum drugs. Silicon nanomaterials themselves are well-known for improving drug delivery, being themselves non-toxic, and versatile, and tailored surface chemistry. This review summarizes the current state-of-the-art within constructs of silicon-containing nano-carriers conjugated and complexed with platinum based drugs. Contrary to a number of other reviews, it stresses the role of nano-chemistry as a primary tool in the development of novel prodrugs.
first_indexed 2024-03-10T08:11:45Z
format Article
id doaj.art-82bbbb600c4c40c78b559ed0839efcee
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T08:11:45Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-82bbbb600c4c40c78b559ed0839efcee2023-11-22T10:40:40ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-012217926410.3390/ijms22179264Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An OverviewKinga Piorecka0Jan Kurjata1Wlodzimierz A. Stanczyk2Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, PolandCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, PolandCentre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, PolandThe development in the area of novel anticancer prodrugs (conjugates and complexes) has attracted growing attention from many research groups. The dangerous side effects of currently used anticancer drugs, including cisplatin and other platinum based drugs, as well their systemic toxicity is a driving force for intensive search and presents a safer way in delivery platform of active molecules. Silicon based nanocarriers play an important role in achieving the goal of synthesis of the more effective prodrugs. It is worth to underline that silicon based platform including silica and silsesquioxane nanocarriers offers higher stability, biocompatibility of such the materials and pro-longed release of active platinum drugs. Silicon nanomaterials themselves are well-known for improving drug delivery, being themselves non-toxic, and versatile, and tailored surface chemistry. This review summarizes the current state-of-the-art within constructs of silicon-containing nano-carriers conjugated and complexed with platinum based drugs. Contrary to a number of other reviews, it stresses the role of nano-chemistry as a primary tool in the development of novel prodrugs.https://www.mdpi.com/1422-0067/22/17/9264anticancer platinum drugsnanoconjugatesnanocomplexes synthesis and propertiessilicon containing nanocarriers
spellingShingle Kinga Piorecka
Jan Kurjata
Wlodzimierz A. Stanczyk
Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
International Journal of Molecular Sciences
anticancer platinum drugs
nanoconjugates
nanocomplexes synthesis and properties
silicon containing nanocarriers
title Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
title_full Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
title_fullStr Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
title_full_unstemmed Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
title_short Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview
title_sort nanoarchitectonics complexes and conjugates of platinum drugs with silicon containing nanocarriers an overview
topic anticancer platinum drugs
nanoconjugates
nanocomplexes synthesis and properties
silicon containing nanocarriers
url https://www.mdpi.com/1422-0067/22/17/9264
work_keys_str_mv AT kingapiorecka nanoarchitectonicscomplexesandconjugatesofplatinumdrugswithsiliconcontainingnanocarriersanoverview
AT jankurjata nanoarchitectonicscomplexesandconjugatesofplatinumdrugswithsiliconcontainingnanocarriersanoverview
AT wlodzimierzastanczyk nanoarchitectonicscomplexesandconjugatesofplatinumdrugswithsiliconcontainingnanocarriersanoverview